TipRanks
Clinuvel Pharmaceuticals Limited (DE:UR9)
FRANKFURT:UR9
Germany Market
UR9
Clinuvel Pharmaceuticals
RESEARCH TOOLSreports

Clinuvel Pharmaceuticals (UR9) Balance Sheet

2 Followers

Clinuvel Pharmaceuticals Balance Sheet

Clinuvel Pharmaceuticals 's total assets for Q4 2026 were AU$296.15M, an increase of 9.81% from the previous quarter. DE:UR9 total liabilities were AU$23.27M for the fiscal quarter, a 12.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Assets
AU$ 296.15MAU$ 271.75MAU$ 231.12MAU$ 194.52MAU$ 144.81M
Total Liabilities
AU$ 23.27MAU$ 30.94MAU$ 28.11MAU$ 29.89MAU$ 19.25M
Total Equity Gross Minority
AU$ 272.88MAU$ 240.81MAU$ 203.01MAU$ 164.63MAU$ 125.56M
Other Metrics
Currency in AUD

Clinuvel Pharmaceuticals Debt to Assets